InvestorsHub Logo
Followers 4
Posts 76
Boards Moderated 0
Alias Born 01/02/2014

Re: der246 post# 21452

Monday, 12/15/2014 11:35:08 PM

Monday, December 15, 2014 11:35:08 PM

Post# of 30990
Another tidbit..in the shareholder meeting DR M explains the MOA but says that it is a very "simplified" explanation.Get it....it's very complex BUT he gets it and understands it. He fully understands how and why it works. He knows the complex scientific version. That's why he's here. Why are they formulating 6 time released doses with the help of Quotient,a european company. Why are they paying Quotient and Quintiles and doing all of this?Is it because they don't have funding or they are not going forward?

Why 2 applications? Why not just 1? Sounds like 2 different studies? Could there be 2 different partners?There are lots of different drug companies in the US and Ireland and these companies go after different conditions.

Hold onto your shares.You can lose 15 cents per share.If a drug approval is granted...If it even looks promising I think you could make allot more than 15 cents per share...You might even make 15 dollars per share! Maybe that explains why Mullen is here. Or maybe he's fooled all the Roskamp and Nilvad scientists...time will tell.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.